Skip to main content

ORIGINAL RESEARCH article

Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 12 - 2024 | doi: 10.3389/fpubh.2024.1486603

A cross-sectional study exploring the predictors of herpes zoster vaccination for people aged over 50 years old in Chaoyang district, Beijing

Provisionally accepted
Jiao Zhang Jiao Zhang 1shuo zhang shuo zhang 2*bin jia bin jia 1*yunhua bai yunhua bai 1*zhen li zhen li 1*fang liu fang liu 1*yingxue hu yingxue hu 1*xiaojing guo xiaojing guo 1,3*jianxin ma jianxin ma 1*shuming li shuming li 1*qian shi qian shi 1*
  • 1 Beijing Chaoyang District Center for Disease Prevention and Control, Beijing, China
  • 2 State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, Fujian Province, China
  • 3 Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

The final, formatted version of the article will be published soon.

    Vaccination is an effective measure to prevent herpes zoster and its related complications. The coverage of herpes zoster vaccination is extremely low in China, and there is a notable lack of research investigating the barriers to promoting the herpes zoster vaccine in China.Objectives: This study aims to survey the status of herpes zoster (HZ) vaccination and its associated factors among individuals aged 50 years and older, it also seeks to identify the barriers to vaccination and dissemination, thereby providing a scientific foundation for enhancing the vaccination rate of herpes zoster; Methods: From March to August 2023, a questionnaire survey was conducted using a multi-stage sampling method on permanent residents aged 50 years and older in Chaoyang District of Beijing. Logistic regression analysis and decision tree models were employed to explore the predictors herpes zoster vaccination behavior; Results: The herpes zoster vaccination coverage was 13.26% (403/3040), with 52.4% of respondents expressing willingness but not yet receiving the vaccine, while 34.31% (1043/3040) were unwilling to be vaccinated. Among those willing but not vaccinated, 48.06% cited high cost as the reason for abstaining from vaccination. Multivariate logistic regression analysis revealed that certain factors were associated with lower vaccination coverage, including being female, having a low frequency of influenza episodes (less than twice per year), and having chronic diseases. On the other hand, higher vaccination coverage was observed among individuals whose spouses had a master's degree or higher, those awarded that a history of chickenpox may lead to potential herpes zoster infection, those who were knowledgeable about the herpes zoster vaccine, and those received recommendations from medical staff. Additionally, the decision tree model confirmed that recommendations from medical staff had the most significant impact on vaccination; Conclusion: The survey reveals a generally low vaccination coverage of the herpes zoster vaccine among residents aged over 50 in this area. It is recommended to enhance the role of medical staff in advocating for vaccination, conduct community-based educational initiatives that focus on varicella, herpes zoster, and related knowledge, and alleviate the financial burden to improve the herpes zoster vaccination coverage.

    Keywords: Herpes Zoster, The herpes zoster vaccine, Vaccination coverage, predictor, Questionnaire survey

    Received: 26 Aug 2024; Accepted: 31 Dec 2024.

    Copyright: © 2024 Zhang, zhang, jia, bai, li, liu, hu, guo, ma, li and shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    shuo zhang, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, 361102, Fujian Province, China
    bin jia, Beijing Chaoyang District Center for Disease Prevention and Control, Beijing, China
    yunhua bai, Beijing Chaoyang District Center for Disease Prevention and Control, Beijing, China
    zhen li, Beijing Chaoyang District Center for Disease Prevention and Control, Beijing, China
    fang liu, Beijing Chaoyang District Center for Disease Prevention and Control, Beijing, China
    yingxue hu, Beijing Chaoyang District Center for Disease Prevention and Control, Beijing, China
    xiaojing guo, Beijing Chaoyang District Center for Disease Prevention and Control, Beijing, China
    jianxin ma, Beijing Chaoyang District Center for Disease Prevention and Control, Beijing, China
    shuming li, Beijing Chaoyang District Center for Disease Prevention and Control, Beijing, China
    qian shi, Beijing Chaoyang District Center for Disease Prevention and Control, Beijing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.